Ixtlan Bioscience

Ixtlan Bioscience is an Israel-based biotechnology company dedicated to defining and utilizing microdoses of psilocybin to advance safe and accessible psilocybin-based treatments aimed at slowing the progression of Alzheimer’s disease and dementia. Focused on neuroscience, neuropsychiatry, Alzheimer’s, and dementia, the company is patenting the Ixtlan AD Kit for home treatment of patients with Alzheimer’s disease and dementia.